HG BIOTECH CONSULTING LTD

Follow this company
Executive Summary

HG Biotech Consulting Ltd shows a solid financial foundation with strong liquidity and positive net assets for a startup business. The company maintains healthy cash reserves and manageable liabilities, indicating good short-term financial health. Moving forward, the focus should be on expanding revenue, managing cash flow prudently, and scaling operations strategically to ensure sustainable growth.

View Full Analysis Report →
Company Documents

DateDescription
11/07/2511 July 2025 Director's details changed for Mr Pandelakis Georgiou on 2025-07-11

View Document

11/07/2511 July 2025 Change of details for Mr Pandelakis Georgiou as a person with significant control on 2025-07-11

View Document

04/07/244 July 2024 Total exemption full accounts made up to 2024-03-31

View Document

31/03/2431 March 2024 Annual accounts for year ending 31 Mar 2024

View Accounts

05/10/235 October 2023 Confirmation statement made on 2023-08-29 with no updates

View Document

29/08/2329 August 2023 Current accounting period extended from 2023-10-31 to 2024-03-31

View Document

06/10/226 October 2022 Incorporation

View Document

More Company Information
Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
    • Follow this company